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new, and provision of more information on patient num-We thank Drs. Udgiri, Kashyap, and Minz for their
bers, case-mix characteristics, and statistical significancecomments and suggestions. However, the data of Meier-
between adjusted and unadjusted groups, particularly inKriesche et al referred to a retrospective analysis of
the 34 BMI category, would help the readers to better51,927 renal transplants registered in United States Re-
understand the ramifications of this finding.nal Data System (USRDS). Our data were drawn from
Figure 3 in the paper of Lowrie, Ofsthun, and Lazarusa single center experience on quite a smaller number of
[1] supports the statement that small and underweightpatients. Only one of our patients had a body mass index
patients are susceptible to underdialysis. However, it(BMI) higher than 36 kg/m2, which according to Meier-
should be noted that given the current practice of hemo-Kriesche, has the highest risk of graft failure. After 14
dialysis in the United States, it would be uncommon toyears, the allograft of this patient is still functioning with
find a small or underweight patient receiving lower dosea serum creatinine was 2.0 mg/dL. We considered an-
of dialysis; for instance, the frequency of underweightother 14 patients with BMI higher than 30 kg/m2. Their
patients with a standard prescription Kt/V of 1.2 wasgraft survival probability at 15 years was 92.8%, their
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in small and underweight patients than normal or over-On the other hand, Meier-Kriesche et al interpreted
weight patients. Thus, it is more common to see under-with caution their own data. They pointed out that it
weight patients receiving more dialysis than overweightwas difficult to ascertain whether the poor death-censored
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a better survival [3]. The point is that once the patienthypertension. Moreover, they found that also a low BMI
receives a certain amount of dialysis, the survival is lessincreased the risk of late failure. It is difficult to advocate
dependent on dialysis dose delivered per treatment, butany role for an insufficient nephron mass in the latter
more to factors such as nutrition and comorbid condi-patients.
tions.Although the potential role of nephron underdosing
Thus, the extremely low Kt that is used by Lowrie,in chronic allograft nephropathy (CAN) is intellectually
Ofsthun, and Lazarus in underweight patients to demon-attractive and worth of further investigation, we think
strate the deleterious effect of underdialysis in such pa-that the risk of glomerular hyperfiltration caused by an
tients is outside the range obtained in regular clinicalinadequate nephron mass of the donor is overwhelmed
practice. Therefore, we are concerned that the reportedby many other more relevant risk factors.
results of the statistical analysis may be based on extrapo-
lation outside the plausible data with a few cases thatClaudio Ponticelli and Margarita Villa
Milan, Italy may exhibit undue influence on the regression. We think
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what is important is to provide adequate and perhaps
frequent than three times a week dialysis, and then to
attend to the nutritional and other risk factors that we
now know contribute to significant morbidity and mor-
tality in dialysis population.
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Third, we have evaluated the association of absoluteWe thank Dr. Salahudeen and Dr. May for their inter-
[e.g., body surface area (BSA) or weight) and relativeest and respond in reverse order of their four paragraphs.
(e.g., BMI or weight/height) body size with death riskFirst, the Kt data were taken from 43,334 patients
as part of several published and unpublished projects.receiving actual treatment so the low Kt data were not
The absolute measures almost always show a straightoutside a clinical practice range. Note that a 100-pound
(log) linear association [1, 3]. The relative measures al-woman would receive only about 27 to 30 L of treatment
most always show a curvilinear relationship similar to
(Kt) at a target Kt/V of 1.2.
that shown in our first figure [3].
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pretation (of a true observation that small patients have of dialysis. However, it did suggest that dose (Kt) should
higher Kt/V than large patients but worse survival) sug- not be indexed to body size (e.g., V) as a simple ratio
gesting that dialysis dose higher than a particular thresh- (e.g., Kt/V) no matter treatment frequency.
old, presumably described as Kt/V, is not beneficial. We
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